When was The University of Tokyo Edge Capital founded?

The University of Tokyo Edge Capital was founded in 2004.

Where is The University of Tokyo Edge Capital headquartered?

The University of Tokyo Edge Capital is headquartered in Tokyo, Japan.

What is The University of Tokyo Edge Capital's total asset value?

The University of Tokyo Edge Capital has around in total assets under management.

How many investments has The University of Tokyo Edge Capital made?

The University of Tokyo Edge Capital has made 258 investments.

What has The University of Tokyo Edge Capital invested in?

The University of Tokyo Edge Capital has made numerous investments in companies like EnVision Endoscopy , Celaid Therapeutics , and United Immunity within the Surgical Devices, Drug Discovery, and Biotechnology industries.

What has The University of Tokyo Edge Capital invested in recently?

The University of Tokyo Edge Capital's latest investment was on 10-Nov-2026 in EnVision Endoscopy , a company within the Surgical Devices industry.

The University of Tokyo Edge Capital investment portfolio

The University of Tokyo Edge Capital Overview

Investor Type

Venture Capital

Status

Active

Professionals

15

Investments

258

Portfolio

89

Exits

66

The University of Tokyo Edge Capital General Information

Company Description

Founded in 2004, The University of Tokyo Edge Capital is a venture capital firm based in Tokyo, Japan. The firm invests in healthcare, life science, information and communication technology, clean technology, physical science, and manufacturing technology sectors based in Japan.

Business Details

Website

www.ut-ec.co.jp

Year Founded

2004

Investor Status

Actively Seeking New Investments

Trade Association

Indian Venture Capital Association (INVCA)

Japan Venture Capital Association (JVC)

Principles for Responsible Investment (PRI)

Primary Investor Type

Venture Capital

Corporate Office

3rd Floor, South Research Building (Entrepreneur Lab)
University of Tokyo, 7-3-1 Hongo, Bunkyo-ku
Tokyo, 113-8485
Japan

+81







The University of Tokyo Edge Capital Investments (258)

Company Name	Deal Date	Deal Type	Industry	Company Stage
EnVision Endoscopy	10-Nov-2026	Later Stage VC	Surgical Devices	Generating Revenue
Celaid Therapeutics	04-Oct-2026		Drug Discovery	Generating Revenue
United Immunity	24-Sep-2026		Biotechnology	Clinical Trials - Phase 2
RegCell	15-Sep-2026		Biotechnology	Pre-Clinical Trials
TriOrb	07-Aug-2026		Electronic Equipment and Instruments	Generating Revenue
X Mile	04-Aug-2026		Human Capital Services	Generating Revenue
Piece (Financial Services)	13-Jul-2026		Other Financial Services	Generating Revenue
Kuzen	07-Jul-2026		Business/Productivity Software	Generating Revenue
Nordstar Partners	01-Jul-2026	Later Stage VC	Private Equity	Generating Revenue
ALGO ARTIS	09-Jun-2026	Later Stage VC	Media and Information Services (B2B)	Generating Revenue

You’re viewing 10 of 258 investments. Get the full list »

Want detailed data on 11M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

The University of Tokyo Edge Capital Exits (66)

Company Name	Exit Date	Exit Type
estie	06-Nov-2026	IPO
Tier IV	22-Jul-2026
CREWT	01-Apr-2026
TAGCyx Biotechnologies	01-Mar-2026
Vegetalia	01-Mar-2026
Kepler (Japan)	17-Sep-2025
Nelumbo	02-Apr-2025
ZenmuTech	27-Mar-2025
ARCH (Medical Records Systems)	26-Nov-2024	Early Stage VC
GlyTech	01-Aug-2024	Merger/Acquisition

You’re viewing 10 of 66 exits. Get the full list »

The University of Tokyo Edge Capital Investments by Industry, Year, and Region

Investments by Industry

Investments by Year

Investments by Region

PitchBook’s data visualizations quickly surface an investor’s historical investments—showing a breakdown of activity by industry, year and region.